-+ 0.00%
-+ 0.00%
-+ 0.00%

Nolato (OM:NOLA B) Stock Faces EPS Compression As Steady Revenue Tests Bullish Growth Narratives

Simply Wall St·07/19/2026 01:26:16
Listen to the news

Nolato (OM:NOLA B) has put fresh numbers on the table for Q2 2026, with revenue of SEK2.5b, basic EPS of SEK0.63 and net income of SEK169m framing the latest quarter. The company has seen quarterly revenue move between SEK2.3b and SEK2.5b over the past six periods, while basic EPS has ranged from about SEK0.56 to SEK0.80. This gives investors a clear view of how the top and bottom line have tracked together into this print. With net profit margin around 7.6% and only marginally different from last year, the focus this quarter is on how steady profitability lines up with the growth expectations now attached to the stock.

See our full analysis for Nolato.

With the headline figures set, the next step is to see how these results compare with the widely followed narratives around Nolato, and where the numbers either support or push back against those stories.

See what the community is saying about Nolato

OM:NOLA B Revenue & Expenses Breakdown as at Jul 2026
OM:NOLA B Revenue & Expenses Breakdown as at Jul 2026

Steady SEK2.5b revenue with EPS moving in a tighter band

  • Across the last six quarters, Nolato’s revenue has held in a narrow SEK2.3b to SEK2.5b range, while basic EPS has moved between about SEK0.56 and SEK0.80, showing that profit per share has been a bit more variable than sales.
  • Analysts' consensus view links this steady top line to expansion in medical, electronics and sustainable materials, yet the recent trailing twelve month picture shows earnings of SEK716m on SEK9.4b of revenue, which sits alongside concerns that five year earnings have declined about 9.3% per year.
    • Supporters of the consensus point to healthcare and connectivity demand as drivers for those SEK9,425m in trailing revenue, suggesting the business mix can support the current 7.6% net margin.
    • At the same time, critics of the consensus highlight that trailing net profit of SEK716m and a margin slightly below last year’s 7.7% leave little room for error if those end markets cool or growth in medical and engineered solutions slows.

7.6% margin and free cash flow pressure

  • Nolato’s trailing net profit margin sits at 7.6%, just below last year’s 7.7%, while the dividend yield of about 3.68% is flagged as not being well covered by free cash flow.
  • Bears argue that high capital expenditure and overcapacity risks could squeeze these margins further and keep free cash flow tight, and the current data gives some support to that concern.
    • With SEK716m of net income on SEK9,425m of revenue over the last twelve months, even a small drop in utilization at new facilities in Hungary, Malaysia or Poland could have a visible effect on net profit if costs stay high.
    • The warning that the 3.68% dividend is not well covered by free cash flow means that if earnings dip below the recent SEK169m to SEK215m quarterly band, management could face harder choices between maintaining the payout and funding ongoing expansion.
For investors focused on the more cautious case around Nolato’s capex and margins, there is a deeper breakdown of the downside arguments in the 🐻 Nolato Bear Case.

P/E of 17.4x versus DCF fair value of SEK101.52

  • At a share price of SEK46.25 and trailing P/E of 17.4x, Nolato trades below a DCF fair value of SEK101.52 and below a peer average P/E of 29.5x, while sitting slightly above the European Industrials average of 16.6x.
  • Bullish investors see this gap to DCF fair value and the analyst price target of SEK63.67 as a key part of their case, and the current figures give them several talking points along with some checks.
    • The combination of SEK716m in trailing net income, a 7.6% margin and a P/E of 17.4x is used by bulls to argue that the current price does not fully reflect forecasts for around 15.4% annual earnings growth and 8.2% annual revenue growth.
    • However, the same valuation data also has to be weighed against the five year earnings decline of about 9.3% per year and the weaker free cash flow coverage of the dividend, which remind investors that the upside implied by SEK63.67 and SEK101.52 is not risk free.
If you want to see how supporters frame the upside case around these valuation gaps and growth forecasts for Nolato, check out the 🐂 Nolato Bull Case

Next Steps

To see how these results tie into long-term growth, risks, and valuation, check out the full range of community narratives for Nolato on Simply Wall St. Add the company to your watchlist or portfolio so you'll be alerted when the story evolves.

With a mix of concerns and optimism around Nolato in this article, it is worth checking the full picture and forming your own view using the 3 key rewards and 1 important warning sign.

See What Else Is Out There Beyond Nolato

Nolato’s mix of a 7.6% net margin, weaker free cash flow coverage of its 3.68% dividend and past earnings decline leaves some investors worrying about resilience.

If those questions around earnings consistency and dividend coverage make you cautious, compare Nolato with companies screened for stronger financial cushions using the 291 resilient stocks with low risk scores.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.